miR-21 is up-regulated in psoriasis and suppresses T cell apoptosis

Experimental Dermatology

Volumn 21, Issue 4, 2012, Pages 312-314

  Meisgen, Florian ^a   Xu, Ning ^a   Wei, Tianling ^a   Janson, Peter C ^a   Obad, Susanna ^b   Broom, Oliver ^b   Nagy, Nikoletta ^c   Kauppinen, Sakari ^b,d   Kemény, Lajos ^c   Ståhle, Mona ^a   Pivarcsi, Andor ^a   Sonkoly, Enikö ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Santaris Pharma AS   (Denmark)

^c UNIVERSITY OF SZEGED   (Hungary)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

Chronic inflammation; Inflammatory skin disease; MicroRNA; Skin; T cells

Indexed keywords

MICRORNA 21;

APOPTOSIS; CELL TYPE; CONTROLLED STUDY; DERMIS; ECZEMA; EPIDERMIS CELL; EXPERIMENTAL DESIGN; HELPER CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; LETTER; LYMPHOCYTE DIFFERENTIATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SKIN INFLAMMATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UPREGULATION;

APOPTOSIS; CASE-CONTROL STUDIES; CELLS, CULTURED; HUMANS; LYMPHOCYTE ACTIVATION; MICRORNAS; PSORIASIS; SKIN; T-LYMPHOCYTES; UP-REGULATION;

EID: 84858397752     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01462.x     Document Type: Letter

References (25)

1. Farazi T A, Spitzer J I, Morozov P et al. J Pathol 2011: 223: 102-115.
2. Xiao C, Rajewsky K. Cell 2009: 136: 26-36.
3. Sonkoly E, Wei T, Janson P C et al. PLoS ONE 2007: 2: e610.
4. Zibert J R, Lovendorf M B, Litman T et al. J Dermatol Sci 2010: 58: 177-185.
5. Gu X, Nylander E, Coates P J et al. Acta Derm Venereol 2011: 91: 392-397.
6. Holst L M, Kaczkowski B, Gniadecki R. Reproducible pattern of microRNA in normal human skin. Exp Dermatol 2010: 19: e201-e205.
7. Volinia S, Calin G A, Liu C G et al. Proc Natl Acad Sci USA 2006: 103: 2257-2261.
8. Fulci V, Chiaretti S, Goldoni M et al. Blood 2007: 109: 4944-4951.
9. Cheng Y, Ji R, Yue J et al. Am J pathol 2007: 170: 1831-1840.
10. Sheedy F J, Palsson-McDermott E, Hennessy E J et al. Nat Immunol 2010: 11: 141-147.
11. Chan J A, Krichevsky A M, Kosik K S. Cancer Res 2005: 65: 6029-6033.
12. van der Fits L, van Kester M S, Qin Y et al. J Invest Dermatol 2011: 131: 762-768.
13. Si M L, Zhu S, Wu H et al. Oncogene 2007: 26: 2799-2803.
14. Iliopoulos D, Kavousanaki M, Ioannou M et al. Eur J Immunol 2011: 41: 1754-1763.
15. Stagakis E, Bertsias G, Verginis P et al. Ann Rheum Dis 2011: 70: 1496-1506.
16. Janson P C, Marits P, Thorn M et al. J Immunol 2008: 181: 2878-2886.
17. Obad S, dos Santos C O, Petri A et al. Nat Genet 2011: 43: 371-378.
18. Sabat R, Philipp S, Hoflich C et al. Exp Dermatol 2007: 16: 779-798.
19. Salaun B, Yamamoto T, Badran B et al. J Transl Med 2011: 9: 44.
20. Wu H, Neilson J R, Kumar P et al. PLoS ONE 2007: 2: e1020.
21. Di Cesare A, Di Meglio P, Nestle F O. J Invest Dermatol 2009: 129: 1339-1350.
22. Mease P J. Ann Rheum Dis 2002: 61: 298-304.
23. Bak R O, Stenderup K, Rosada C et al. BMC Dermatol. 2011: 11: 5.
24. Jakobsen M, Stenderup K, Rosada C et al. Mol Ther 2009: 17: 1743-1753.
25. Chang T, Sun L, Wang Y et al. Exp Dermatol 2011: 20: 555-560.